Author:
Liu Hanyou,Li Jingying,Wang Xue,Luo Shiqi,Luo Dan,Ge Wei,Ma Chao
Abstract
AbstractAlzheimer’s disease (AD) is recognized as the predominant cause of dementia, and neuroimmune processes play a pivotal role in its pathological progression. The involvement of long non-coding RNAs (lncRNAs) in AD has attracted widespread attention. Herein, transcriptomic analysis of 262 unique samples extracted from five hippocampal–entorhinal system subfields of individuals with AD pathology and without AD pathology revealed distinctive lncRNA expression profiles. Through differential expression and coexpression analyses, we identified 16 pivotal lncRNAs. Notably, RN7SL1 knockdown significantly modulated microglial responses upon oligomeric amyloid-β stimulation, resulting in a considerable decrease in proinflammatory cytokine production and subsequent neuronal damage. These findings highlight RN7SL1 as an essential neuroimmune-related lncRNA that could serve as a prospective target for AD diagnosis and treatment.
Funder
College Students Innovative Training Plan Program
National Natural Science Foundation of China
CAMS Innovation Fund for Medical Sciences
STI2030-Major Project
Publisher
Springer Science and Business Media LLC
Reference74 articles.
1. United Nations Department of Economic and Social Affairs PD. World Population Ageing 2020: highlights. Living Arrangements of Older Persons; 2020.
2. Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222–34.
3. Hardy J, Schott JM. Identifying genetic risk for amyloid-related imaging abnormalities. Neurology. 2024;102(3):e208096.
4. Giap BT, Jong CN, Ricker JH, Cullen NK, Zafonte RD. The hippocampus: anatomy, pathophysiology, and regenerative capacity. J Head Trauma Rehabil. 2000;15(3):875–94.
5. Murphy C. Olfactory and other sensory impairments in Alzheimer disease. Nat Reviews Neurol. 2019;15(1):11–24.